Katie Couric on Yahoo News brings some light to chronically low sexual desire, called HSDD (Hypoactive Sexual Desire Disorder) which is a real problem for many women.
“We know there is this area of the limbic system that is associated with the neurotransmitters dopamine and norepinephrine that is functioning differently in the women with HSDD,” says Leah Millheiser, MD, director of the Female Sexual Medicine Program at Stanford School of Medicine.
Sprout Pharmaceuticals is resubmitting its drug Flibanserin, otherwise known as the “little pink pill,” to the FDA for approval. If approved, it would be the first of its kind to treat women with HSDD (Hypoactive Sexual Desire Disorder.)
“Flibanserin is a novel, non-hormonal pill to treat hypoactive sexual desire disorder in premenopausal women,” says Sprout CEO Cindy Whitehead.
View this informative video – here!
